Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Angiodynamics Inc's Business Segments
Angiodynamics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q4 ((May 31 2026))
Reportable Segments
3
Largest Segment
Med Device
Total Revenue
$ 87
Regions Reported
1
Revenue Share by Reportable Segment - Q4 ((May 31 2026))
- Med Device196.5%
- Med Tech173.1%
- Non-US52.2%
Revenue by Reportable Segment - Q4 ((May 31 2026))
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Med Device | $ 170 | 196.5% |
| Med Tech | $ 150 | 173.1% |
| Non-US | $ 45 | 52.2% |
Revenue Share by Region - Q4 ((May 31 2026))
- United States317.4%
Revenue by Geographic Region - Q4 ((May 31 2026))
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| United States | $ 275 | 317.4% |
Annual Results
Revenue Share by Reportable Segment - FY2026
- Med Device53.2%
- Med Tech46.8%
Revenue by Reportable Segment - FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Med Device | $ 170 | 53.2% |
| Med Tech | $ 150 | 46.8% |
Revenue Share by Region - FY2026
- Non-US14.1%
Revenue by Geographic Region - FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 45 | 14.1% |
Revenue by Product & Service Category - FY2026
- Med Device45.3%
- Med Tech40.5%
Revenue by Product & Service Category - FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Med Device | $ 145 | 45.3% |
| Med Tech | $ 130 | 40.5% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Angiodynamics Inc
AngioDynamics Inc is a leading provider of innovative medical technologies and devices for minimally-invasive surgical procedures that are used in hospitals, clinics, and physician offices worldwide. The company's product portfolio includes medical devices that are designed to diagnose, treat, and manage a wide range of medical conditions, including peripheral vascular disease, cancer, and other serious medical conditions.
AngioDynamics was founded in Queensbury, New York, in 1988, and has since grown to become a global medical technology company. The company operates in more than 60 countries and employs over 1,400 people worldwide. The company's headquarters is located in Latham, New York.
The product portfolio of AngioDynamics includes a variety of medical devices and technologies that are used in interventional procedures including:
1. Peripheral Vascular Interventions: AngioDynamics offers a variety of products to diagnose and treat peripheral artery disease. These include the market-leading VenaCure EVLT laser system for treatment of varicose vein and the AngioVac cannula and circuit for extraction of clot in various vascular procedures.
2. Oncology: AngioDynamics provides a variety of technologies to diagnose and treat cancer, including the NanoKnife Irreversible Electroporation System, which uses electrical pulses to kill cancer cells.
3. Interventional Radiology: AngioDynamics' interventional radiology products include the BioFlo PICC, which is designed to reduce complications associated with central venous catheterization and the Bioflo Port, a power-injected, long-term use catheter.
4. Surgical Oncology: AngioDynamics offers a variety of products for surgical oncology, including radiofrequency ablation (RFA), microwave ablation, and cryoablation systems for the treatment of solid tumors.
In addition to its product portfolio, AngioDynamics also has a strong focus on research and development. The company invests a significant amount of resources in the development of new technologies and devices for minimally-invasive surgical procedures.
AngioDynamics has a strong reputation for quality and innovation, and its products are used by medical professionals across the globe. With its broad portfolio of medical technologies, AngioDynamics is well-positioned to continue growing and advancing the field of minimally-invasive surgical procedures.
AngioDynamics was founded in Queensbury, New York, in 1988, and has since grown to become a global medical technology company. The company operates in more than 60 countries and employs over 1,400 people worldwide. The company's headquarters is located in Latham, New York.
The product portfolio of AngioDynamics includes a variety of medical devices and technologies that are used in interventional procedures including:
1. Peripheral Vascular Interventions: AngioDynamics offers a variety of products to diagnose and treat peripheral artery disease. These include the market-leading VenaCure EVLT laser system for treatment of varicose vein and the AngioVac cannula and circuit for extraction of clot in various vascular procedures.
2. Oncology: AngioDynamics provides a variety of technologies to diagnose and treat cancer, including the NanoKnife Irreversible Electroporation System, which uses electrical pulses to kill cancer cells.
3. Interventional Radiology: AngioDynamics' interventional radiology products include the BioFlo PICC, which is designed to reduce complications associated with central venous catheterization and the Bioflo Port, a power-injected, long-term use catheter.
4. Surgical Oncology: AngioDynamics offers a variety of products for surgical oncology, including radiofrequency ablation (RFA), microwave ablation, and cryoablation systems for the treatment of solid tumors.
In addition to its product portfolio, AngioDynamics also has a strong focus on research and development. The company invests a significant amount of resources in the development of new technologies and devices for minimally-invasive surgical procedures.
AngioDynamics has a strong reputation for quality and innovation, and its products are used by medical professionals across the globe. With its broad portfolio of medical technologies, AngioDynamics is well-positioned to continue growing and advancing the field of minimally-invasive surgical procedures.
Angiodynamics Inc. is a prominent medical technology company dedicated to the design, development, and marketing of innovative devices and services tailored for minimally invasive medical procedures. The company primarily revolves around offering advanced solutions in two significant medical segments: Peripheral Vascular and Oncology/Surgery. Each segment encompasses a variety of products designed to address specific medical conditions while enhancing patient care and procedural efficiency.
Segments
1. Peripheral Vascular:
This segment emphasizes the creation and distribution of cutting-edge devices aimed at diagnosing and treating peripheral vascular diseases (PVD). Peripheral vascular disease often leads to decreased blood flow to the extremities, which can have serious health implications. Angiodynamics offerings in this segment are engineered to be effective, safe, and minimally invasive, thereby improving patient outcomes and recovery times.
2. Oncology / Surgery:
Focusing on cancer treatment and surgical interventions, this segment includes an array of products and services designed for the diagnosis, treatment, and management of tumors. The tools provided in this segment cater to various oncological needs, from localized treatment options to broader diagnostic technologies, ensuring a comprehensive approach to oncology care.
Products
Peripheral Vascular:
1. AngioVac:
- The AngioVac system is a sophisticated device for the retrieval of large blood clots or debris from the venous system. It operates through a suction cannula that is introduced into the affected vein, connecting to an extracorporeal circuit that facilitates the removal of clots or foreign material. This device is particularly crucial for patients suffering from deep vein thrombosis or other clot-related issues.
2. Endovascular:
- This product line features a diverse range of minimally invasive devices aimed at addressing peripheral vascular disease. Key components include angioplasty balloons used to dilate narrowed or obstructed blood vessels, stents that help keep these vessels open, and atherectomy systems designed to remove atherosclerotic plaque from the arteries.
3. Laser Ablation Systems:
- Angiodynamics offers advanced solutions like the VenaCure EVLT (Endovenous Laser Treatment) laser system, utilizing targeted laser energy for the effective ablation of varicose veins. The VenaCure 1470 laser system further specializes in the endovenous ablation of incompetent perforator veins, illustrating the company’s commitment to improving minimally invasive venous procedures.
Oncology/Surgery:
1. Embolization Therapy:
- A critical aspect of cancer treatment, this product line comprises a variety of vascular occlusion devices, including microspheres, coils, and plugs. These tools are designed to block blood flow to tumors, effectively starving them of the nutrients they need to grow, and can be utilized in a range of oncological procedures.
2. Radiofrequency Ablation:
- Angiodynamics provides an array of radiofrequency ablation devices that utilize thermal energy to destroy cancerous tumors. This technique can be employed in various settings, allowing for precise targeting of tissue with minimal damage to surrounding structures.
3. Biopsy Devices:
- For accurate diagnosis and treatment planning, Angiodynamics offers specialized biopsy systems, such as the AccuStick trocar system and the AccuCore biopsy system. These devices enable clinicians to obtain tissue samples efficiently and reliably for pathological evaluation, aiding in the diagnosis and management of cancer.
Services
In addition to their extensive product offerings, Angiodynamics Inc. is dedicated to providing comprehensive support services aimed at optimizing the usage of its products in clinical settings:
1. Clinical Support:
- Angiodynamics provides an array of clinical education resources delivered by a team of trained clinical specialists. This support ensures that healthcare providers are well-informed on the latest techniques and best practices associated with the use of their products.
2. Reimbursement Support:
- Understanding the complexities of healthcare finance, Angiodynamics offers reimbursement support services. This helps healthcare providers navigate the intricacies of coding and billing processes, assisting them in securing appropriate reimbursement for their innovative products.
3. Training Services:
- To guarantee effective product utilization, Angiodynamics offers a variety of training services. These programs are designed to thoroughly instruct healthcare providers on the proper operation of their devices, ensuring proficient application in clinical practice.
Conclusion
Overall, Angiodynamics Inc. is committed to advancing the field of medical technology by providing an extensive range of minimally invasive devices and services. Through its focus on the Peripheral Vascular and Oncology/Surgery segments, Angiodynamics delivers innovative solutions that address critical medical needs while enhancing patient care and safety. The company’s dedication to clinical education, training, and reimbursement support further underscores its commitment to improving healthcare outcomes and enabling healthcare providers to deliver the best possible care to their patients.
Segments
1. Peripheral Vascular:
This segment emphasizes the creation and distribution of cutting-edge devices aimed at diagnosing and treating peripheral vascular diseases (PVD). Peripheral vascular disease often leads to decreased blood flow to the extremities, which can have serious health implications. Angiodynamics offerings in this segment are engineered to be effective, safe, and minimally invasive, thereby improving patient outcomes and recovery times.
2. Oncology / Surgery:
Focusing on cancer treatment and surgical interventions, this segment includes an array of products and services designed for the diagnosis, treatment, and management of tumors. The tools provided in this segment cater to various oncological needs, from localized treatment options to broader diagnostic technologies, ensuring a comprehensive approach to oncology care.
Products
Peripheral Vascular:
1. AngioVac:
- The AngioVac system is a sophisticated device for the retrieval of large blood clots or debris from the venous system. It operates through a suction cannula that is introduced into the affected vein, connecting to an extracorporeal circuit that facilitates the removal of clots or foreign material. This device is particularly crucial for patients suffering from deep vein thrombosis or other clot-related issues.
2. Endovascular:
- This product line features a diverse range of minimally invasive devices aimed at addressing peripheral vascular disease. Key components include angioplasty balloons used to dilate narrowed or obstructed blood vessels, stents that help keep these vessels open, and atherectomy systems designed to remove atherosclerotic plaque from the arteries.
3. Laser Ablation Systems:
- Angiodynamics offers advanced solutions like the VenaCure EVLT (Endovenous Laser Treatment) laser system, utilizing targeted laser energy for the effective ablation of varicose veins. The VenaCure 1470 laser system further specializes in the endovenous ablation of incompetent perforator veins, illustrating the company’s commitment to improving minimally invasive venous procedures.
Oncology/Surgery:
1. Embolization Therapy:
- A critical aspect of cancer treatment, this product line comprises a variety of vascular occlusion devices, including microspheres, coils, and plugs. These tools are designed to block blood flow to tumors, effectively starving them of the nutrients they need to grow, and can be utilized in a range of oncological procedures.
2. Radiofrequency Ablation:
- Angiodynamics provides an array of radiofrequency ablation devices that utilize thermal energy to destroy cancerous tumors. This technique can be employed in various settings, allowing for precise targeting of tissue with minimal damage to surrounding structures.
3. Biopsy Devices:
- For accurate diagnosis and treatment planning, Angiodynamics offers specialized biopsy systems, such as the AccuStick trocar system and the AccuCore biopsy system. These devices enable clinicians to obtain tissue samples efficiently and reliably for pathological evaluation, aiding in the diagnosis and management of cancer.
Services
In addition to their extensive product offerings, Angiodynamics Inc. is dedicated to providing comprehensive support services aimed at optimizing the usage of its products in clinical settings:
1. Clinical Support:
- Angiodynamics provides an array of clinical education resources delivered by a team of trained clinical specialists. This support ensures that healthcare providers are well-informed on the latest techniques and best practices associated with the use of their products.
2. Reimbursement Support:
- Understanding the complexities of healthcare finance, Angiodynamics offers reimbursement support services. This helps healthcare providers navigate the intricacies of coding and billing processes, assisting them in securing appropriate reimbursement for their innovative products.
3. Training Services:
- To guarantee effective product utilization, Angiodynamics offers a variety of training services. These programs are designed to thoroughly instruct healthcare providers on the proper operation of their devices, ensuring proficient application in clinical practice.
Conclusion
Overall, Angiodynamics Inc. is committed to advancing the field of medical technology by providing an extensive range of minimally invasive devices and services. Through its focus on the Peripheral Vascular and Oncology/Surgery segments, Angiodynamics delivers innovative solutions that address critical medical needs while enhancing patient care and safety. The company’s dedication to clinical education, training, and reimbursement support further underscores its commitment to improving healthcare outcomes and enabling healthcare providers to deliver the best possible care to their patients.